🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share our work on broadly effective phage-antibiotic cocktails. We report 3 cocktails that each work against >95% of 153 antibiotic resistant Pseudomonas isolates. Check it out here: nature.com/articles/s4146… Congrats to Kevin Kim @KevinMinyo6651

We are so excited to welcome our new class of ID Fellows for next year – what an amazing group!!

.@KevinMinyo6651 (Stanford University) etal published a paper on designing effective #phage-antibiotic cocktails against infections, showing that combining phages targeting different bacterial receptors can prevent resistance & effectively treat MDR infections buff.ly/49hWfhE

Excited to show our recent review on phage therapy! Many thanks to Paul Bollyky Jessica Sacher, PhD JCI - Bacteriophage therapy for multidrug-resistant infections: current technologies and therapeutic approaches jci.org/articles/view/…

Congrats to Kevin Minyoung Kim and Jessica Sacher, PhD on their review of phage therapy production and drug development. It was great working with Dr. Sabrina Green, PhD, Jean-Paul Pirnay, Rob Lavigne, Gina Suh and the rest of the team on this project jci.org/articles/view/…

Personalized or one-size-fits-all: the phage therapy field's favorite binary. Or is it a spectrum? Excited to share our new Journal of Clinical Investigation review, a team effort spanning Stanford University, Mayo Clinic, KU Leuven & QAMH, driven forward by the incredible Kevin Minyoung Kim! 🧵 /1